Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look
- 1 September 1990
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 38 (3) , 392-395
- https://doi.org/10.1016/0090-8258(90)90080-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after. Second-look laparotomyCancer, 1989
- Ovarian carcinoma: Abdominopelvic irradiation following reexplorationGynecologic Oncology, 1988
- Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.Journal of Clinical Oncology, 1986
- COMPLETE REMISSION AT LAPAROTOMY: STILL A GOLD STANDARD IN OVARIAN CANCER?The Lancet, 1986
- Advanced epithelial ovarian cancer: Toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperationGynecologic Oncology, 1986
- A review of second-look laparotomy for ovarian cancerGynecologic Oncology, 1986
- Results of radiation therapy in the treatment of epithelial carcinoma of the ovaryCancer, 1980
- Second-look operation in ovarian carcinoma.PostchemotherapyCancer, 1976